Xtant Net Income From Continuing Ops from 2010 to 2024

XTNT Stock  USD 0.37  0.01  2.63%   
Xtant Medical Net Income From Continuing Ops yearly trend continues to be comparatively stable with very little volatility. Net Income From Continuing Ops is likely to outpace its year average in 2024. From the period from 2010 to 2024, Xtant Medical Net Income From Continuing Ops quarterly data regression had mean square error of 425 T and mean deviation of  13,076,511. View All Fundamentals
 
Net Income From Continuing Ops  
First Reported
2010-03-31
Previous Quarter
-3.9 M
Current Value
-5 M
Quarterly Volatility
10.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Xtant Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xtant Medical's main balance sheet or income statement drivers, such as Interest Expense of 5.3 M, Total Revenue of 53.7 M or Gross Profit of 34 M, as well as many indicators such as Price To Sales Ratio of 1.4, Dividend Yield of 0.0 or PTB Ratio of 2.49. Xtant financial statements analysis is a perfect complement when working with Xtant Medical Valuation or Volatility modules.
  
Check out the analysis of Xtant Medical Correlation against competitors.

Latest Xtant Medical's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Xtant Medical Holdings over the last few years. It is Xtant Medical's Net Income From Continuing Ops historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Xtant Medical's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Pretty Stable
   Net Income From Continuing Ops   
       Timeline  

Xtant Net Income From Continuing Ops Regression Statistics

Arithmetic Mean(14,643,326)
Coefficient Of Variation(136.70)
Mean Deviation13,076,511
Median(10,507,869)
Standard Deviation20,017,083
Sample Variance400.7T
Range73M
R-Value0.12
Mean Square Error425T
R-Squared0.02
Significance0.66
Slope549,550
Total Sum of Squares5609.6T

Xtant Net Income From Continuing Ops History

20242.9 M
20232.8 M
2022-8.5 M
2021-4.8 M
2020-7 M
2019-8.2 M
2018-70.1 M

About Xtant Medical Financial Statements

Xtant Medical shareholders use historical fundamental indicators, such as Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Xtant Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Xtant Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Xtant Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Income From Continuing Ops2.8 M2.9 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Xtant Stock Analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.